References
- Hassan SM, Hamza N, Jaffer Al-Lawatiya F, et al. Extended molecular spectrum of β- and α-thalassemia in Oman. Hemoglobin. 2010;34(2):127–134
- Daar S, Hussain HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann N Y Acad Sci 1998;850:404–406
- Al Sultan A, Phanasgaonkar S, Suliman A, et al. Spectrum of β-thalassemia mutations in the eastern province of Saudi Arabia. Hemoglobin. 2011;35(2):125–134
- Baysal E. Molecular basis of β-thalassemia in the United Arab Emirates. Hemoglobin. 2011;35(5–6):581–588
- Al Hazmi MA, Warsy AS, Al Swailem AR. The frequency of 14 β-thalassemia mutations in the Arab population. Hemoglobin. 1995;19(6):353–360
- Strauss BS. Genetic counseling for thalassemia in the Islamic Republic of Iran. Perspect Biol Med. 2009;52(3):364–376
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296
- Miri-Moghaddam E, Zadeh-Vakili A, Rouhani Z, et al. Molecular basis and prenatal diagnosis of β-thalassemia among Balouch population in Iran. Prenat Diagn. 2011;31(8):788–791
- Yavarian M, Harteveld CL, Batelaan D, et al. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001;25(1):35–43
- Al Zadjali S, Wali Y, Al Lawatiya F, et al. The β-globin promoter −71 C > T mutation is a β+ thalassemic allele. Eur J Haematol. 2011;87(5):457–460
- Al Zadjali S, Daar S, Al Kindi S, et al. Hb Sheffield [β58(E2)Pro→His] in Oman: Potential pitfall in genetic counseling. Hemoglobin. 2011;35(2):111–116
- Belhoul KM, Bakir ML, Abdulrahman M. Misdiagnosis of Hb D-Punjab/β-thalassemia is a potential pitfall in hemoglobinopathy screening programs: A case report. Hemoglobin. 2013;37(2):119–123